Edesa Biotech in-licenses two COVID-19 candidates; shares up 21% [Seeking Alpha]
Edesa Biotech, Inc. - Common Shares (EDSA)
Company Research
Source: Seeking Alpha
Thinly traded nano cap Edesa Biotech (EDSA+21.1%agreementThe monoclonal antibodies inhibit the signaling proteins TLR4 and CXCL10, respectively.Under the terms of the deal, Edesa will issue $2.5M of Series A-1 Convertible Preferred Stock to Light Chain subject to meeting certain milestones, near-term consideration of $6.0M for inventory and other milestone fees, up to $363.5M in development, regulatory and sales milestones and royalties on net sales.
Show less
Read more
Impact Snapshot
Event Time:
EDSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDSA alerts
High impacting Edesa Biotech, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
EDSA
News
- Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Edesa Biotech to Participate in Bloom Burton Healthcare Investor ConferenceAccesswire
- Edesa Biotech to Participate in Upcoming Investor ConferencesAccesswire
- Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory ConferenceAccesswire
- Edesa Biotech to Participate in Barclays Global Healthcare ConferenceAccesswire
EDSA
Analyst Actions
- 2/14/24 - HC Wainwright
EDSA
Sec Filings
- 4/5/24 - Form ARS
- 4/5/24 - Form DEFA14A
- 4/5/24 - Form DEF
- EDSA's page on the SEC website